← SynDRA
RADIPRODIL
SynDRA canonical compound SYN0005634 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | GRIN2B |
|---|
| Mechanism of action | acetylcholine receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- GRIN1 ANTAGONIST
- Glutamate NMDA receptor; GRIN1/GRIN2B antagonist
- GRIN2B ANTAGONIST
- acetylcholine receptor antagonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- CP2D6
- GRIN2A
- GRIN2C
- GRIN2D
- GRIN3A
- GRIN3B
Cross-references
Synonyms
- RGH-896
- AC1L338E
- 1-[2-[[[[[5beta-[(Octadecylaminocarbonyloxy)methyl]tetrahydrofuran]-2beta-yl]methoxy]oxylatophosphinyl]oxy]ethyl]quinolinium
- [[[(2R)-5beta-[[(Octadecylcarbamoyl)oxy]methyl]tetrahydrofuran]-2beta-yl]methyl][2-(quinolinium-1-yl)ethyl] phosphate
- [(2S,5R)-5-[[hydroxy(2-quinolin-1-ium-1-ylethoxy)phosphoryl]oxymethyl]oxolan-2-yl]methyl N-octadecylcarbamate
- RGH 896
- 5XGC17ZKUF
- radiprodilum
- RefChem:178549
- Radiprodil [INN]
- Radiprodil (RGH-896)
- UNII-5XGC17ZKUF
- Radiprodil?
- Radiprodil (USAN/INN)
- RADIPRODIL [USAN]
- RADIPRODIL [WHO-DD]
- SCHEMBL99256
- orb1301835
- SCHEMBL29376763
- SCHEMBL29819486
- GKGRZLGAQZPEHO-UHFFFAOYSA-N
- BDBM50149684
- s6644
- AKOS030257575
- NCGC00386549-01
- AC-38128
- BS-16896
- DA-77335
- HY-14777
- CS-0003554
- NS00071811
- T5385
- D13319
- N16882
- F832586
- RGH-896 dihydrate
- Radiprodil dihydrate
- FOQSBLBAJDFAEC-UHFFFAOYSA-N
Look up RADIPRODIL in the interactive SynDRA portal →